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Background: An altered gut microbiota composition has recently been linked to obesity. The principal aim of this
study is to investigate and compare the gut microbiota composition in obese and lean children. Secondly,
associations between analysed gut bacterial species, dietary compounds, energy intake and biochemical blood
parameters are evaluated.
Methods: In this prospective cross-sectional study, 26 overweight/obese (mean BMI: 28.7 ± 6.5) and 27 lean (mean
BMI: 16.5 ± 2.1) children aged 6 to 16 were included. Faecal samples were collected and subjected to selective
plating and quantitative real-time PCR (qPCR) in order to determine the concentrations of bacterial species
belonging to the genera: Bacteroides, Bifidobacterium, Clostridium, Staphylococcus and Lactobacillus. Matrix-assisted
laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) was applied for an in-depth
identification of species of Bacteroides fragilis group. Differences in the concentrations of gut bacterial species
between obese and lean children were statistically analysed using Mann Whitney U test. Subsequently, random
forest analysis and multiple linear regression analysis were performed in order to test associations between gut
bacterial species, dietary compounds and blood parameters.
Results: Obese children showed an elevated Firmicutes-to-Bacteroidetes ratio compared with lean children.
Furthermore, low relative proportions of B. vulgatus and high concentrations of Lactobacillus spp. were observed in
the obese microbiota. In all children, Staphylococcus spp. were positively associated with energy intake. Additionally,
in obese children, Lactobacillus spp. were positively associated with plasma hs-CRP.
Conclusions: Our findings corroborate a significant difference in the gut microbiota composition of important
bacterial species between obese and lean children. In future, non-invasive manipulation of gut microbiota
composition in early infancy could offer a new approach to manage childhood obesity and associated disorders.
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Although there is evidence that the prevalence of child-
hood obesity is stabilising at different levels in different
countries [1], the number of children and adolescents
being overweight or obese is still dramatically high [2,3].
The major concern is that these children are at high risk* Correspondence: liene.bervoets@uhasselt.be
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reproduction in any medium, provided the orof developing severe co-morbidities such as metabolic
syndrome, non-alcohol fatty liver disease, type 2 diabetes
mellitus and premature cardiovascular diseases [4,5].
Moreover, obese children are highly prone to become
obese adults, especially when having a high body mass
index (BMI) or an obese parent [6,7]. In order to combat
childhood obesity and related complications, prevention
is crucial. At the moment, the most important strategies
to manage childhood obesity are therapeutic lifestyle
changes, such as changing dietary habits and the phys-
ical activity level. However, these are often difficult tol Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 General characteristics of the studied population
O/O (n = 26) C (n = 27) p value
Anthropometric data
Gender (F/M), n 12/14 11/16 0.691
Age, y 11.64 ± 2.43 10.70 ± 3.12 0.229
Height, cm 153.6 ± 15.7 144.7 ± 18.6 0.063
Weight, kg 69.8 ± 25.1 35.7 ± 12.6 < 0.0001*
BMI, kg/m2 28.73 ± 6.53 16.48 ± 2.10 < 0.0001*
BMI SDS 2.69 ± 0.80 −0.43 ± 0.96 < 0.0001*
Dietary data
Number, n 22 25
Energy, kcal/d 2 231.95 ± 437.69 2 082.32 ± 446.79 0.254
Carbohydrates, en% 45.68 ± 9.55 48.81 ± 6.28 0.199
Fat, en% 40.08 ± 9.73 38.59 ± 6.01 0.537
Protein, en% 14.43 ± 3.94 14.48 ± 6.54 0.976
Dietary fibre, g/d 19.26 ± 8.33 15.64 ± 7.33 0.120
O/O: obese group; C: control group; BMI SDS: body mass index standard
deviation score. *Significant differences with p value < 0.05.
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pharmacological interventions and possibly bariatric sur-
gery could be considered.
Nowadays, it is generally accepted that the develop-
ment of obesity is caused by gene-environment inter-
actions, generating a chronic positive energy balance [8].
However, physiological and environmental predisposi-
tions underlying obesity and associated metabolic disor-
ders are still underexplored. Recent evidence suggests
that our gut microbiota is involved in energy regulation
as well as inflammation [9], and should therefore be
considered as an environmental factor playing a role in
the pathophysiology of obesity [10,11]. Although energy
intake can affect the gut microbiota composition [12], it
is still unclear whether the gut microbiota play a causal
role in the development of obesity in humans.
So far, several studies in humans and mice have
shown differences in gut microbiota composition bet-
ween obese and lean subjects. These differences were
mostly detected at the phylum level of mainly Firmicutes
and Bacteroidetes [11-14]. Obesity in humans has
already been associated with low intestinal concen-
trations of Bacteroidetes and high concentrations of
Firmicutes, although this finding has been contradicted
by other studies [15,16]. Only few studies have investi-
gated the prevalence of faecal bacterial phyla in obese
children and adolescents. One study demonstrated low
concentrations of Bacteroidetes and high concentrations
of Firmicutes in the distal gut of obese adolescents living
in Spain [17]. Another study in Sweden, did not find sig-
nificant differences in the concentrations of Bacteroides
fragilis group, Lactobacillus spp. and Bifidobacterium
spp. between preschool children with excessive body
weight and normal-weight children [18]. By contrast,
Vael et al. [19] demonstrated that a high intestinal con-
centration of Bacteroides fragilis group present in early
infancy was associated with a higher risk of obesity later
in life. In general, limited and contradictory findings
with regard to the composition of the gut microbiota in
obese children indicate that further in-depth analysis of
the role of the intestinal microbiota in childhood obesity
is warranted.
The principal aim of this study is to evaluate and com-
pare the presence of certain gut bacterial species in fae-
cal samples of obese and lean children and adolescents.
Quantitative culturing was used to identify and de-
termine the concentrations of the following bacterial
genera: Bacteroides fragilis group, Bifidobacterium, Clos-
tridium, Staphylococcus and Lactobacillus. In addition to
quantitative culturing, matrix-assisted laser desorption/
ionization mass spectrometry (MALDI-TOF MS) was
used for in-depth analysis of species belonging to the
Bacteroides fragilis group. Quantitative real-time poly-
merase chain reaction (qPCR) was applied to quantifyBacteroides-Prevotella-Porphyromonas spp., Bifidobac-
terium spp., Clostridium coccoides-Eubacterium rectale
group, Clostridium leptum group, Staphylococcus spp.
and Lactobacillus spp. The Firmicutes-to-Bacteroidetes
ratio was calculated based on the qPCR results. Finally,
analysed gut bacterial species were associated with diet-
ary compounds and energy intake, which were assessed
by dietary records. Moreover, concentrations of bioche-




Characteristics of the study population are shown in
Table 1. In total, 9 overweight, 7 obese, 10 morbidly
obese (O/O) children and 21 normal-weight, 5 thinness
grade I and 1 thinness grade III (C) children were in-
cluded (see Methods section for details on BMI classifi-
cation). Age, gender, height and dietary intake were not
significantly different between the two study groups.
Quantification of bacterial genera and species of
Bacteroides fragilis group
Differences in the concentrations of bacterial genera be-
tween O/O and C children are presented in Figure 1A, B
and C. Figure 1A illustrates differences between gut mi-
crobiota in O/O and C children detected by quantitative
plating. Bacteroides fragilis group and Clostridium spp.
were borderline, but non-significantly different between
O/O and C children (5.69 ± 2.14 vs. 6.66 ± 0.84 and
5.94 ± 1.10 vs. 6.31 ± 0.80, respectively; p = 0.050 and
p = 0.074). In-depth analysis of species belonging to the
Bacteroides fragilis group using MALDI-TOF MS re-
vealed dominating relative proportions of B. fragilis
Figure 1 Differences in bacterial genera between O/O and C group. A: Differences in bacterial genera between O/O and C detected by
quantitative plating. B: Differences in relative proportions of Bacteroides fragilis group species between O/O and C detected by MALDI-TOF MS. C:
Differences in bacterial genera between O/O and C detected by qPCR. Data of quantitative plating and qPCR are expressed as mean log10 cells/g
of faeces. Data of MALDI-TOF MS are reported in percentages (%). O/O: obese group; C: control group. Error bars 95% CI. **p = 0.004. *p = 0.04.
Bervoets et al. Gut Pathogens 2013, 5:10 Page 3 of 10
http://www.gutpathogens.com/content/5/1/10(17.3% vs. 6.1%, p = 0.136) and B. thetaiotaomicron
(11.5% vs. 7.5%, p = 0.930) in faecal samples of O/O chil-
dren compared with C children (Figure 1B). By contrast,
in C children, relative proportions of B. caccae (10.7%
vs. 4.0%, p = 0.051), B. ovatus (9.3% vs. 7.6%, p = 0.585),
B. uniformis (6.3% vs. 1.5%, p = 0.177) and B. vulgatus
(21.7% vs. 6.2%, p = 0.004) prevailed. Note that only B.
vulgatus proportions were significantly different between
the O/O and C children. Figure 1C shows differences
found between gut bacterial species in O/O and C chil-
dren detected by qPCR. In contrast to the quantitativeplating results, faecal concentrations of Lactobacillus
spp. were found to be significantly higher in O/O com-
pared with C children and adolescents (6.44 ± 1.20 vs.
5.69 ± 1.80, p = 0.035) using qPCR.The Firmicutes-to-Bacteroidetes ratio
In Figure 2, a boxplot of the Firmicutes-to-Bacteroidetes
ratio of O/O and C children is presented. The ratio
resulted in favour of the Firmicutes in O/O children and
adolescents (p = 0.007).
Figure 2 Firmicutes-to-Bacteroidetes ratio of O/O versus C
children. O/O: obese group; C: control group. *p = 0.007.
Bervoets et al. Gut Pathogens 2013, 5:10 Page 4 of 10
http://www.gutpathogens.com/content/5/1/10Dietary assessment
The most important associations between analysed gut
bacterial species, dietary compounds and energy intake
in a subsample of 22 O/O and 25 C children are pre-
sented in Table 2. Children and adolescents with a high
daily energy intake showed high faecal concentrations of
Staphylococcus spp., analysed by means of quantitative
plating (p = 0.028).
Biochemical markers
Important biochemical markers were measured in fas-
ting venous blood samples of 19 obese children (see
Material and Method section for more details on blood
sampling procedure). The following mean values were
obtained: fasting plasma glucose: 82.44 ± 5.34 mg/dl;
fasting plasma insulin: 21.58 ± 17.31 μU/ml; total choles-
terol (TC): 176.26 ± 42.14 mg/dl; high-density lipopro-
tein (HDL) cholesterol: 49.61 ± 10.05 mg/dl; triglycerides
(TG): 112.63 ± 81.92 mg/dl; leukocytes: 7.86 ± 2.42%;Table 2 Most important associations between gut microbiota
coefficient β (p value)
Carbohydrates (en%)
Quantitative plating
Bacteroides fragilis group 0.127 (0.110)
Bifidobacterium spp. −0.025 (0.410)
Clostridium spp.
Staphylococcus spp.
Lactobacillus spp. 0.069 (0.360)
qPCR
Bacteroides-Prevotella-Porphyromonas spp. 0.048 (0.319)
Bifidobacterium spp. 0.017 (0.439)
Clostridium coccoides-Eubacterium rectale group
Clostridium leptum group
Staphylococcus spp. −0.093 (0.203) −
Lactobacillus spp. 0.052 (0.503)
Regression coefficient with 95% CI. *Significant association with p value < 0.05.high-sensitive C-reactive protein (hs-CRP): 0.46 ± 0.36
mg/dl; alanin aminotransferase (ALT): 38.12 ± 19.82 U/l;
aspartate aminotransferase (AST): 33.94 ± 12.79 U/l. The
most important associations between major gut micro-
biota species and the concentration of the biochemical
markers are presented in Table 3. Intestinal concen-
trations of Lactobacillus spp., which were analysed by
quantitative plating, showed a positive association with
plasma hs-CRP levels (p = 0.007).
Discussion
At birth, the gut microbiota of an infant is sterile but
rapidly assembles over days or months [20]. Mode of de-
livery (natural delivery versus caesarean section) and
feeding method (breast feeding versus bottle feeding)
have an early impact on the development of a child’s gut
microbiome [21]. At the age of four, the gut microbiota
is fully mature [22]. Eventually, each person develops a
unique gut microbiota which is stable over time in
healthy adults [23].
In this cross-sectional study, the obese gut microbiota
composition was compared with that of a lean one.
We focused on two major phyla Bacteroidetes and
Firmicutes, next to the Bacteroides fragilis group, Bi-
fidobacterium, Clostridium, Staphylococcus and Lactoba-
cillus. Different bacterial groups were selected according
to the frequency to which they have been described in
relevant literature [17-19,24] and the ease of detection
by the techniques used. On the one hand, quantitative
plating was used as the ‘gold standard’ technique to iso-
late and characterise the selected bacterial groups. How-
ever, only 10 to 50% of all bacteria associated with the
human body can be cultivated successfully [23,25]. Subse-
quently, high-throughput culture-independent techniques,and dietary compounds represented by regression
Dietary compounds
Fat (en%) Protein (en%) Fibre (g/d) Energy intake (kcal/d)









0.084 (0.285) −0.083 (0.075) 0.000 (0.691)
0.069 (0.401) −0.000 (0.993) 0.010 (0.745) 0.000 (0.415)
Table 3 Most important associations between biochemical parameters, gut microbiota and BMI SDS represented by
regression coefficient β (p value)
Biochemical markers
Leukocytes Glucose Insulin HDL-C TG TC ALT AST hs-CRP
(%) (mg/dl) (μU/ml) (mg/dl) (mg/dl) (mg/dl) (U/l) (U/l) (mg/l)
Quantitative plating
Bacteroides fragilis group −1.469 −1.677 −6.926
(0.237) (0.099) (0.497)
Bifidobacterium spp. 0.830 5.673 −1.619 −0.124
(0.631) (0.719) (0.753) (0.969)
Clostridium spp. −0.276 0.071 −3.725 2.322 22.353 −3.598
(0.562) (0.967) (0.343) (0.932) (0.181) (0.245)
Staphylococcus spp. 1.718 −30.933 −32.137
(0.414) (0.381) (0.122)






Clostridium coccoides-Eubacterium rectale group 0.860 0.825 1.259 33.654 −3.686 −6.465 0.285




Lactobacillus spp. −1.307 1.342 17.604 −5.764 6.274 −0.004
(0.518) (0.703) (0.468) (0.717) (0.139) (0.979)
BMI SDS 0.726 2.449 1.008 2.588 75.925 29.824 19.310 10.655 0.181
(0.469) (0.392) (0.900) (0.406) (0.086) (0.207) (0.072) (0.117) (0.390)
Regression coefficient with 95% CI. *Significant association with p value < 0.05.
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RNA subunit, were applied in order to assign an organism
to a phylogenetic classification more accurately [25].
To our knowledge, our study was the first to perform an
in-depth analysis of species belonging to the Bacteroides
fragilis group by means of MALDI-TOF MS. Overall, our
results reveal a high Firmicutes-to-Bacteroidetes ratio in
faeces of obese children including alterations at species
level.
Selective media have been used successfully to identify
and enumerate Bacteroides fragilis group from human
faeces [26]. For the first time, a further in-depth analysis
of species of the Bacteroides fragilis group revealed re-
duced relative proportions of B. vulgatus in obese chil-
dren and adolescents. One study reported decreased
relative proportions of B. vulgatus in the faeces of type 2
diabetic subjects using species specific PCR-denaturing
gradient gel electrophoresis (DGGE) [27]. B. vulgatus
was found to constitute a part of the core gut microbiota
in healthy humans and is generally considered to be a
beneficial gut commensal [28]. These findings pointtowards a possible role for B. vulgatus in the pathophysi-
ology of Western diseases, such as obesity and diabetes.
Moreover, the qPCR method that was used in this
study to detect and quantify Bacteroidetes (Bacteroides-
Prevotella-Porphyromonas spp.), Firmicutes (Clostridium
coccoides-Eubacterium rectale group, Clostridium lep-
tum group, Staphylococcus spp. and Lactobacillus spp.),
and Bifidobacterium spp. in human faeces has already
been thoroughly evaluated and validated [29-31]. In
agreement with the findings of previous studies [32,33],
we describe higher concentrations of Lactobacillus spp.
in the obese gut microbiota. However, the use of quanti-
tative plating did not permit the detection of a signifi-
cantly higher concentration of Lactobacillus spp. in
faeces of obese children, which we did see using qPCR.
A possible explanation is that L. gasseri and L. acido-
philus could not be identified in culture due to the
presence of vancomycin in the LAMVAB medium [34].
Nevertheless, both quantitative culturing and qPCR
resulted in a similar proportion of Lactobacillus spp. in
the obese gut microbiota. A study conducted by Million
Bervoets et al. Gut Pathogens 2013, 5:10 Page 6 of 10
http://www.gutpathogens.com/content/5/1/10et al. [32], demonstrated that Lactobacillus reuteri was
associated with obesity in adults. By contrast, Santacruz
et al. [33] showed that BMI SDS reduction in obese ado-
lescents led to a concomitant increase in the concentra-
tions of Lactobacillus spp. These findings thus suggest a
possible role of Lactobacillus at species level in body
weight and obesity. Additionally, we showed that the
concentration of Lactobacillus spp. is positively corre-
lated to plasma hs-CRP levels in obese children and ado-
lescents. An increased prevalence of positive Firmicutes
to higher levels of plasma hs-CRP was also seen in a
study conducted in 51 obese and 28 normal-weight chil-
dren and adults [35]. These results seems therefore to
suggest a possible role for Lactobacillus spp. in “low-
grade” inflammation, a major pathophysiological process
of obesity.
Interestingly, we detected an elevated Firmicutes-to
-Bacteroidetes ratio in the gut microbiota of obese chil-
dren and adolescents. Previous investigators also showed
significant associations between this ratio and obesity in
mice and humans [11-14]. The results of our study are
similar to a study in Spanish children, demonstrating
increased concentrations of Firmicutes and decreased
concentrations of Bacteroidetes in the obese gut [17]. Con-
trary to these findings, other studies described no or even
opposite differences in the Firmicutes-to-Bacteroidetes ra-
tio between obese and lean subjects [15,16]. Possibly, these
variations in study outcome are related to the fact that dif-
ferent methodologies were applied in these studies.
To further elucidate the complex role of gut micro-
biota in host physiology, a more thorough examination
of the influence of diet on gut microbiota is re-
commended. In order to do so, we analysed the rela-
tionship between the presence of certain gut bacterial
species with dietary compounds and energy intake. Here,
we demonstrate that, independent of the BMI status,
children and adolescents with a high energy intake
(expressed in kcal/d) possess high faecal concentrations
of Staphylococcus spp. analysed by quantitative culture.
Note that the regression coefficient β of energy intake is
low in all cases. This is due to the fact that values of en-
ergy intake are expressed in kcal/d. Given the range of
energy intake (1635.53 to 2669.64 kcal), results in effect
on mean concentration of Staphylococcus spp. of 1.27 to
2.08 are obtained. These results are not negligible and a
real significant association has been detected. However,
caution must be taken when translating these findings
into a biological meaningful interpretation. Hence, more
detailed research on this topic is necessary. Nevertheless,
the importance of Staphylococcus spp. in childhood
obesity has already been demonstrated by Kalliomaki
et al. [24] who showed that a greater faecal concentra-
tion of Staphylococcus spp. during infancy predicted the
development of overweight during childhood. A possiblerole of Staphylococcus spp. in energy harvesting during
childhood is thus suggested.
One major limitation of the current study is the small
sample size and therefore these results should be in-
terpreted with caution. In addition, pregnancy related
factors, social status, and the period of being obese prior
to inclusion were not taken into account.
Further longitudinal research on the cause-effect rela-
tionship between gut microbiota and obesity is highly
justified, since different bacterial species could play a sig-
nificant role in the human energy harvest and weight
regulation. Moreover, consideration of lifestyle factors in
gut microbiota studies is highly recommended, since
changes in dietary pattern and physical activity could
influence gut microbiota composition and the deve-
lopment of obesity. Finally, we suggest to focus future
research not only on the elucidation of gut microbiota
composition in obese subjects, but also on the study of
gut metabolites, i.e. “metabolomics”. This suggestion for
future research aims at expanding our knowledge on the
complex interplay between gut microbiota, energy ho-
meostasis and obesity.
In the future, modification of the gut microbiota com-
position by the administration of pro-, pre- or synbiotics
in early childhood could offer an opportunity to prevent
and/or treat obesity [36]. However, additional research is
required.
Conclusions
In this study, important compositional differences in the
faecal gut microbiota of obese and lean children were
revealed. This was generally reflected by an elevated
Firmicutes-to-Bacteroidetes ratio in the obese study
population. At the species level, low proportions of B.
vulgatus and high concentrations of Lactobacillus spp.
were found in faeces of obese children and adolescents.
Furthermore, the presence of Lactobacillus spp. in the
obese gut microbiota was positively associated with
plasma hs-CRP levels. We also found a positive asso-
ciation between energy intake and the presence of
Staphylococcus spp. in faeces of children, independent of
their BMI status. The aforementioned bacterial genera
and species may thus be more efficient at extracting en-
ergy from a given diet in obese children and adolescents
compared with gut microbiota of lean children. Hence,
B. fragilis group, Lactobacillus spp. and Staphylococcus
spp. play an important role in the pathophysiology of
childhood obesity. We hypothesize that an aberrant gut
microbiota composition in combination with influences
of lifestyle factors might contribute to the development
of childhood obesity. To further confirm this hypothesis,
additional research is required in a longitudinal setting
with recruitment of a larger sample population. Finally,
prevention and treatment strategies based on modification
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contribute to limit the development of future obesity.
Methods
Subject characteristics
Overweight, obese and morbidly obese (O/O: obese
group) children were recruited from the paediatric obe-
sity clinic at the Antwerp University Hospital. Normal-
weight and lean children (C: control group) were
recruited among the offspring of personnel working at
the University of Antwerp. Skilled personnel recorded
weight (scale, SECA 701 scale, Hamburg, Germany) and
height (stadiometer, SECA 225, Hamburg, Germany)
measurements, to the nearest 0.1 kg for weight and 1
mm for height and the BMI (in kg/m2). All subjects were
classified based on the international BMI cut-off values
of the Extended International Obesity Task Force (IOTF)
for children aged 2 to 18 [37]. These values are based on
age and gender-specific centile curves passing through
BMI 35 (morbid obesity), 30 (obesity), 25 (overweight)
and 18.5, 17 and 16 (thinness grades I, II and III) at age
18. BMI standard deviation score (SDS) was assessed
using an electronic calculator (Auxology 1.1, Pfizer, New
York, USA) based on the local reference standards, i.e.
Flemish growth charts [38]. Exclusion criteria included
the use of corticosteroids or antibiotics in the month
prior to the study as well as during the study and signifi-
cant co-morbidities such as an acute infection, prema-
turity or chronic diseases. The study was conducted in
accordance with the ethical rules of the Helsinki Declar-
ation. Informed consent was obtained from all children
and their parents or legal guardian. The study protocol
was approved by the local medical Ethics Committee of
the Antwerp University Hospital (document 7/41/226).
Gut microbiota analyses
Faecal sample collection
A fresh faecal sample was self-collected and stored
immediately at −20°C. The collection took place in the
same week as the dietary record. Subsequently, the fae-
cal samples were transported to the laboratory and
stored at −80°C until further analysis.
Quantitative plating
Approximately 0.5 g of wet faeces was diluted in 9 vol-
umes of phosphate buffer saline (PBS) and homogenized
using a stomacher (Minimix®, Interscience, Arpents,
France). Serial dilutions were plated using the Eddy Jet®
apparatus (Led Techno, Heusden-Zolder, Belgium) onto
the selective growth media. More specifically, Staphylo-
coccus spp. were cultivated on mannitol salt agar (MSA)
(Becton-Dickinson, Erembodegem, Belgium); only yellow
and white colonies were considered [39]. Bacteroides fra-
gilis group was determined on Bacteroides Bile Esculinagar (BBE) (Becton-Dickinson, Erembodegem, Belgium);
only black pigmented colonies were considered [40]. Clos-
tridium spp. counts were obtained after pre-treatment of
the faecal sample in 70% ethanol for 30 minutes and
subsequent culture on Columbia blood agar (CBA) [41].
Lactobacillus spp. were cultured on Lactobacillus anaer-
obic de Man, Rogosa and Sharpe with vancomycin and
bromocresolgreen (LAMVAB) medium; only green and
white colonies were considered [34]. Bifidobacterium spp.
were determined on modified trypticase-phytone-yeast
agar (MTPY); only colonies smaller than 0.7 mm were
considered [42]. To confirm the presence of Bifidobac-
terium spp. in these colonies, a gram stain was conducted.
The numbers of colonies positive for gram stain were
expressed relative to the total number of colonies
examined.
MALDI-TOF MS analysis
Of each sample, ten presumed colonies of Bacteroides
fragilis group were subcultured on Wilkins-Chalgren
medium for 24h and spotted onto a target plate. Matrix-
assisted laser desorption/ionization mass spectrometry
(MALDI-TOF MS) analysis was accomplished according
to the manufacturer’s instructions (Microflex™ LT Bruker
Daltonik GmbH, Bremen, Germany). Recorded mass
spectra generated with the MALDI Biotyper 2.0 software
package were compared with each entry of the MALDI
Biotyper database and relationships were identified. Ac-
cording to the criteria by Nagy et al. [26], only identifi-
cations with a log (score) between 1.9 and 3.0 were
considered to be significant and allowed for identifica-
tion of the bacterial populations at the species level.
Quantitative real-time PCR
DNA extraction An aliquot (200 μl) of faecal suspen-
sion was suspended in 300 μl Tris-SDS solvent, 300 μg
glass beads (diameter, 0.1 mm) and 500 μl TE-saturated
phenol. Further extraction of total bacterial DNA was
performed as described by Matsuki et al. [30]. The mix-
ture was vortexed vigorously with FastPrep® FP120A
(BIO 101® Systems, Thermo Scientific) for 30 s at a
power level of 5.0. After centrifugation for 5 min at 13
000 rpm, 400 μl of the supernatant was collected and
400 μl phenol/chloroform/isoamylalcohol (25:24:1) was
added. Subsequently, 250 μl of the supernatant was
subjected to isopropanol.
qPCR qPCR assay was performed as previously de-
scribed by Rinttilä et al. [31]. All PCR experiments were
carried out in triplicate with a reaction volume of 25 μl.
The reaction mixture contained 7.5 μl sterile Milli-Q;
12.5 μl iQ SYBR Green Supermix and 1.25 μl of 10 μM
of each primer (forward and reverse). Subsequently,
2.5 μl of faecal DNA was added to the reaction mixture.
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each reaction and the total bacterial copy number per
organism was determined with 16S rRNA gene targeted
primers [29-31]. The bacterial primer sequences are re-
ported in Table 4.
The Firmicutes-to-Bacteroidetes ratio An estimation
of the total amount of Firmicutes was obtained by ad-
ding bacterial values (in log10 cells/g faeces) from Clos-
tridium coccoides-Eubacterium rectale group (clostridial
cluster XIV).
Clostridium leptum group (clostridial cluster IV),
Lactobacillus spp. and Staphylococcus spp. For the total
amount of Bacteroidetes, the Bacteroides-Prevotella-
Porphyromonas spp. were taken into consideration. The
ratio was calculated according to Mariat et al. [43].
Dietary assessment
A total of 22 (84.6%) O/O and 25 (92.6%) C children
fully completed a five-day dietary record (three weekdays
and two weekend days). The average daily intake of en-
ergy and nutrients was calculated with the use of Becel
Institute Nutritional Software program. The dietary va-
riables examined in this study were carbohydrates
(energy %), fat (energy %), protein (energy %), fibres
(g/day), and total energy intake (kcal/day).
Biochemical analyses
Blood sampling was initially conducted to detect associ-
ated metabolic and inflammatory complications in the
O/O group. Since only 19 out of 26 fasting venous blood
samples of obese children were available, results of only
these samples were considered. Glucose, total cholesterolTable 4 16S rRNA gene-targeted group specific primers per b








group (clostridial cluster XIV)
CGGTACCTGACTAAGAAGC
AGTTT(C/T)ATTCTTGCGAACG






CCACATCCAGC(A/G)TCCAC(TC), high-density lipoprotein cholesterol (HDL-C), tri-
glycerides (TG), alanine aminotransferase (ALT), aspartate
aminotransferase (AST) and high-sensitive C-reactive pro-
tein (hs-CRP) were measured on Dimension Vista 1500
System (Siemens Healthcare Diagnostics Inc., Neward,
Delaware, USA). Insulin levels were measured using
chemoluminescence (Roche Diagnostics, Rotkreuz,
Switzerland). White blood cell count was performed using
flow cytometry (Advia 2120, Siemens Healthcare Diagnos-
tics Inc., Neward, Delaware, USA).
Statistical analysis
Descriptive and comparative analyses were performed in
IBM SPSS version 20.0 (SPSS Inc., Chicago, IL, USA).
The distribution of the residuals was tested for normality
using the Kolmogorov-Smirnov test with Lilliefors cor-
rection. Independent samples t test was used in case of
no significant deviation from normality. Otherwise the
Mann Whitney U test was used. Chi square (χ2) test of
association was used to compare characteristics between
the O/O and C study groups. Data were presented as
mean with standard deviation (mean ± SD) unless
indicated otherwise. Since bacterial counts followed a
right-skewed distribution, data were log10-transformed.
Bacterial data were expressed as median log10 cells/g of
faeces with interquartile ranges (IQR). Regression ana-
lyses were implemented in R 2.13.1. Explanatory vari-
ables were selected on the basis of a random forest
analysis, i.e. a nonparametric technique that facilitates
the selection of the important variables in a regression
setting [44]. Given the random forest variable import-
ance plot, the most important predictors above a visually




Bacteroides fragilis DSM 2151/LMG 10263 68 [31]
Staphylococcus aureus ATCC 29213 55 [29]
Ruminococcus productus DSM 2950/YIT 6141 55 [31]
Faecalibacterium prausnitzii YIT 6174 50 [30]
Lactobacillus acidophilus LMG 9433 58 [31]
Bifidobacterium longum DSM 20219/YIT 4021 58 [31]
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http://www.gutpathogens.com/content/5/1/10multiple linear regression was applied to quantify the as-
sociations between gut microbiota, diet, biochemical pa-
rameters and BMI SDS controlled for age and gender.
Wilcoxon-signed rank test was used to evaluate the dif-
ference of accuracy between quantitative culturing and
qPCR. Statistical significance was assessed at the 5%
level.
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